Dr Charles Vega believes that primary care will be the chief clinical setting for application of new blood-based biomarkers.

Still, more than 4200 adult patients are on the lung transplant waitlist in the United States, a steady count that has been ...

Popular videos and social media posts have identified cortisol as the main culprit behind facial puffiness, but many ...

SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...

Researchers compared rates of postpartum depression, anxiety, mood disturbance (temporary low or anxious mood requiring no ...

Heat waves were associated with increased adverse events among individuals older than 65 years with both Medicare and ...

A financial navigation (FN) intervention significantly improved financial toxicity scores among patients with cancer, with ...

Children with antineutrophil cytoplasmic antibody–associated vasculitis had similar remissions rates with rituximab and ...

COVID-19 infection increases the risk for autoimmune blistering diseases (AIBDs), specifically pemphigus and bullous ...

Patients with late-onset axial spondyloarthritis (axSpA) are less likely to be positive for human leukocyte antigen B27 (HLA-B27) and have a family history of SpA; they are more likely to present with ...

Acute kidney injury is being redefined as a collection of syndromes, each of which could be targeted by specific biomarkers.

A randomized controlled trial finds no clear benefit of adding bezlotoxumab to FMT in patients with IBD and recurrent C difficile infection.